SECUAH 2021 > Barrios-Gumiel etal 2021

dianas | Vol 10 No 1 | marzo 2021 | e202103fa01

Theoretical development for the discovery of a drug as a treatment of primary dysmenorrhea

Óscar Barrios Gumiel^a, María Cuesta Corral^b, María Delgado Marín^c, María González Morán^d

Universidad de Alcalá

a. oscar.barrios@edu.uah.es  b. mcuesta.1@alumni.unav.es; maria.cuesta@edu.uah.es  c. mariadm.2898@gmail.com  d. gonzaalezmary@gmail.com 

VI Congreso de Señalización Celular, SECUAH 2021.
29 de marzo a 30 de abril, 2021. Universidad de Alcalá. Alcalá de Henares, Madrid. España.

Keywords: Primary dysmenorrhea; Drug discovery

Abstract

Primary dysmenorrhea is a gynecological disease that causes pain at the beginning of menstruation without any identifiable factor that causes it. It is also a very prevalent disease among the female population. However, it has not received the necessary attention to be able to alleviate it. Therefore, we propose a theoretical development whose main objective is to find a drug that specifically mitigates it. In this way, we propose both high-throughput screening (HTS) and pre-clinical studies in vitro and in vivo. All these applying techniques established and recognized by the scientific community. With this, we want to encourage the investigation of primary dysmenorrhea, a disease that is as underlying as it is neglected.